Status:
COMPLETED
Active Choice in the EHR to Promote Statin Therapy
Lead Sponsor:
University of Pennsylvania
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiovascular (CV) events are the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing CV events and mortality, but statins are often e...
Detailed Description
This study will use a randomized, controlled trial to evaluate a health system initiative. Cardiologists randomly assigned to the control arm will receive no interventions. For cardiologists randomly ...
Eligibility Criteria
Inclusion
- Have a cardiologist at the University of Pennsylvania Health System
- Meets 2013 ACC/AHA or NLA guidelines for statin prescription
Exclusion
- Allergy to statins
- Severe renal insufficiency defined as glomerular filtration rate (GFR) less than 30 mL/min or on dialysis
- Adverse reaction to statins including a) myopathy, b)rhabdomyolysis, c)hepatitis
- Pregnant
- On a PCSK9 Inhibitor medication
Key Trial Info
Start Date :
September 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2019
Estimated Enrollment :
23066 Patients enrolled
Trial Details
Trial ID
NCT03271931
Start Date
September 24 2018
End Date
June 5 2019
Last Update
July 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104